Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,841 to 1,860 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| U01CA098758 | Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 | 1 | 2010 |
| U24DC008559 | Otopathology by Light Microscopy and Molecular Techniques | 1 | 2010 |
| UL1RR024148 | Center for Clinical and Translational Sciences | 1 | 2010 |
| R01CA088480 | Hypoxia and Gene Repression | 2 | 2009 |
| R01CA120327 | Molecular Imaging of Cancer In vivo via Targeted Transduction | 2 | 2009 |
| R21NS061128 | In vivo assessment of Gas6 to protect oligodendrocytes and enhance remyelination | 2 | 2009 |
| S10RR025622 | LTQ XL Linear Quadrupole Ion Trap Mass Spectrometer | 2 | 2009 |
| DP2OD006506 | The discovery of microRNAs that predict chemotherapeutic responsiveness of cancer | 1 | 2009 |
| K01AR051367 | Lupus Serum Signaling Through Toll-Like Receptor 9 | 1 | 2009 |
| K24AT000596 | Clinical Studies in Nutrition and Metabolism | 1 | 2009 |
| P20CA101936 | SPORE in Pancreatic Cancer | 1 | 2009 |
| R01AR053358 | Elucidation of Shear-Induced Signaling Networks | 1 | 2009 |
| R01CA088898 | COACTIVATORS IN BREAST DEVELOPMENT AND TUMORIGENESIS | 1 | 2009 |
| R01CA115888 | Role of Downstream Signaling in EGFR/HER2 Inhibitor Radiosentitization | 1 | 2009 |
| R01CA133996 | Statistical Methods for Gene Environment Interactions In Lung Cancer | 1 | 2009 |
| R01DK065837 | PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN | 1 | 2009 |
| R01GM061031 | Uptake of apoptotic cells | 1 | 2009 |
| R01GM061395 | GQ/11-RGS Mediated Signaling | 1 | 2009 |
| R01HL082480 | Innate and adaptive immunity in COPD exacerbations | 1 | 2009 |
| R01NS052507 | Glioblastoma Genome Project to Locate Molecular Targets | 1 | 2009 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=93